Blockade of calcium channels and AT1 receptors prevents the hypertensive effect of calcilytic NPS 2143 in rats

Journal of Physiology and Pharmacology

Volumn 61, Issue 2, 2010, Pages 163-170

  Rybczynska, A ^a   Jurska Jasko, A ^a   Boblewski, K ^a   Lehmann, A ^a   Orlewska, C ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Angiotensin ii; Calcium receptor; Felodipine; Losartan; Mean arterial blood pressure

Indexed keywords

2 CHLORO 6 [3 [1,1 DIMETHYL 2 (2 NAPHTHYL)ETHYLAMINO] 2 HYDROXYPROPOXY]BENZONITRILE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CALCIUM; CALCIUM CHANNEL; CALCIUM RECEPTOR BLOCKING AGENT; FELODIPINE; LOSARTAN; PARATHYROID HORMONE; RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE; THIOPENTAL; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM SENSING RECEPTOR; N (2 HYDROXY 3 (2 CYANO 3 CHLOROPHENOXY)PROPYL) 1,1 DIMETHYL 2 (2 NEPHTHYL)ETHYLAMINE; N-(2-HYDROXY-3-(2-CYANO-3-CHLOROPHENOXY)PROPYL)-1,1-DIMETHYL-2-(2-NEPHTHYL)ETHYLAMINE; NAPHTHALENE DERIVATIVE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MONITORING; BOLUS INJECTION; CALCIUM BLOOD LEVEL; CAROTID ARTERY; CONTROLLED STUDY; DRUG INFUSION; DRUG MECHANISM; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARATHYROID HORMONE RELEASE; RAT; RECEPTOR SENSITIVITY; WISTAR RAT; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; FELODIPINE; HYPERTENSION; LOSARTAN; MALE; NAPHTHALENES; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, CALCIUM-SENSING;

EID: 77955855684     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 2+ sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580.
2. Fox J, Lowe SH, Petty BA, et al. NPS R-568: a type II calcimimetic compound that acts on parathyroid cell calcium receptor of rats to reduce plasma levels of parathyroid hormone and calcium. J Pharmacol Exp Ther 1999; 290: 473-479.
3. Nemeth EF, Bennet SA. Tricking the parathyroid glands with novel calcimimetic agents. Nephrol Dial Transplant 1999; 13: 1923-1925.
4. 2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther 2001; 299: 323-331.
5. Rybczynska A, Boblewski K, Lehmann A, et al. Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats. Am J Hypertens 2005; 18: 364-371.
6. Goodman WG, Frazao JM, Goodkin DA, et al. A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. Kidney Int 2000; 58: 436-445.
7. Gowen M, Stroup GB, Dodds RA, et al. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest 2000; 105: 1595-1604.
8. Rybczynska A, Lehmann A, Jurska-Jasko A, et al. Hypertensive effect of calcilytic NPS 2143 in rats. J Endocrinol 2006; 191: 189-195.
9. Allen AM, Zhuo J, Mendelsohn F. Localization and function of angiotensin AT1 receptors. Am J Hypertens 2000; 13: 31S-38S.
10. Karaki H, Ozaki H, Hori M, et al. Calcium movements, distribution, and functions in smooth muscle. J Physiol 1997; 492: 61-74.
11. Yamakage M, Namiki A. Calcium channels - basic aspects of their structure, function and gene encoding; anesthetic action on the channels - a review. Can J Anesth 2002; 49: 151-164.
12. van Zwieten PA, Pfaffendorf M. Similarities and differences between calcium antagonists: pharmacological aspects. J Hypertens 1993; 11: 3-11.
13. DelMar EG, Barmore RM, Sheehan D, et al. Calcilytic compounds. US Patent 2003; 6: 521-667.
14. Jirgensons A, Kauss V, Kalvinsh I, et al. A practical synthesis of tert-alkyloamines via the Ritter reaction with chloroacetonitrile. Synthesis 2000; 1709-1712.
15. Lewanczuk RZ, Resnik LM, Ho MS, et al. Clinical aspects of parathyroid hypertensive factor. J Hypertens 1994; 12: 11-16.
16. Lewanczuk RZ, Pang PKT. Vascular and calcemic effects of plasma of spontaneously hypertensive rats. Am J Hypertens 1990; 3: 189S-194S.
17. Schluter, H., Kluth B, Borjesson-Stoll R, et al. Partial purification and characterization of a circulating hypertensive factor in spontaneously hypertensive rats. Eur J Biochem 1993; 218: 67-73.
18. Lewanczuk RZ, Wang J, Zhang ZR, et al. Effects of spontaneously hypertensive rat plasma on blood pressure and tail artery calcium uptake in normotensive rats. Am J Hypertens 1989; 2: 26-31.
19. 2+ exchanger inhibitor dichlorobenzamil in cultured human umbilical vein endothelial cells and mouse aortic smooth muscle cells. J Physiol Pharmacol 2009; 60(1): 43-50.
20. + channels in vascular smooth muscle cells. Can J Physiol Pharmacol 1999; 77(11): 860-865.
21. Louhelainen M, Merasto S, Fickenberg P, et al. Effects of calcium sensitizer OR-1986 on cardiovascular mortality and myocardial remodeling in hypertensive Dahl/Rapp rats. J Physiol Pharmacol 2009; 60(3): 41-47.
22. Bottari SP, de Gasparo M, Steckelings M. Angiotensin II receptor subtypes: characterization, signaling mechanisms and possible physiological implications. Front Neuroendocrinol 1993; 14: 123-171.
23. Baksi SN. Hypotensive action of parathyroid hormone in hypoparathyroid and hyperparathyroid rats. Hypertesion 1988; 11: 509-513.
24. Pang PKT, Tenner TE Jr, Yee JA, et al. Hypotensive action of parathyroid hormone preparations on rats and dogs. PNAS 1980; 77: 675-678.
25. Saglikes Y, Massry SG, Iseki K, et al. Effect of PTH on blood pressure and response to vascular agonist. Am J Physiol 1985; 248: F674-F681.
26. Ziegelstein RC, Xiong Y, He C, et al. Expression of functional extracellular calcium-sensing receptor in human aortic endothelial cells. Biochem Biophys Res Commun 2006; 342: 153-163.
27. Tfelt-Hansen J, Hansen JL, Smajilovic S, et al. Calcium receptor is functionally expressed in rat neonatal ventricular cardiomyocytes. Am J Physiol 2006; 290: H1165-H1171.
28. Ohanian J, Gatfield KM, Ward DT, et al. Evidence for a functional calcium-sensing recptor that modulates myogenic tone in rat subcutaneous small arteries. Am J Physiol 2005; 288: H1756-H1762.
29. Smajilovic S, Hansen JL, Christoffersen TE. Extra cellular calcium sensing in rat aortic vascular smooth muscle cells. Biochem Biophys Res Commun 2006; 348: 1215-1223.
30. Farzaneh-Far A, Proudfoot D, Weisberg PL, et al. Matrix gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor. Biochem Biophys Res Commun 2000; 277: 736-740.
31. Wonnenberger K, Scofield MA, Wangemann P. Evidence for a calcium-sensing receptor in the vascular smooth muscle cells of a spiral mediolar artery. J Membr Biol 2000; 175: 203-212.
32. Smajilovic S, Sheykhzade M, Holmegard HN, et al. Calcimimetic, AMG 073, induces relaxation on isolated rat aorta. Vascul Pharmacol 2007; 47: 222-228.